HALO Sleepsack Recall Issued After Infant Chokes on Petal

A recall has been issued for roughly 27,000 wearable zip-up blankets, which were sold exclusively through Babies R Us, as multiple reports have been received of the decorative flower petals detaching, creating a choking hazard for young children.  

The HALO SleepSack wearable blankets recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on August 21, after the manufacturer received at least six complaints of problems, including one report where an infant was found choking on the detached petal.

The recall includes HALO SleepSack wearable blankets with pink satin flowers that have GPU numbers 2701, 2781, 2887, 3007, 3035, and 3142 printed on the neck label. The wearable blankets are sack shaped and have cut outs for sleeves with a zipper down the center. The blankets have a pink ruffle design around the edges and have a pink satin rose sewn on the front.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The affected blankets were manufactured in China under Jiaxing Huayan Fashion Company Ltd of Jiaxing Zhejiang, China were they were imported by Halo Innovations and sold exclusively at Babies R Us stores and online at babiesrus.com from December 2011 through July 2013 for roughly $25.

The CPSC warns consumers to always be cautious when purchasing baby toys or clothing with decorative trimmings such as flowers or beads because children have the tendency to put shiny colored things in their mouth creating choking hazards.

The CPSC also recommends that consumers stop using the recalled blankets immediately and contact Halo Innovation at (866) 819-8118 to receive a prepaid envelope with instructions on how to remove and return the flower and order a free replacement product.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted today)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 2 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.